论文部分内容阅读
肝细胞癌 (ｈｅｐａｔｏｃｅｌｌｕｌａｒｃａｒｃｉｎｏｍａ ,ＨＣＣ)是我国和东亚地区的常见恶性肿瘤之一 ,最佳治疗方法是外科切除 ,而对于多数不能切除的中、晚期肝癌 ,日本学者Ｎａｋａｋｕｍａ[1] 首创的碘油加抗癌药物经肝动脉化疗栓塞治疗大大提高了肝细胞癌患者的生存
Hepatocellular carcinoma (HCC) is one of the most common malignancies in China and East Asia. The best treatment is surgical resection. For the majority of unresectable intermediate and advanced hepatocellular carcinoma, Japanese scholar Nakakuma [1] initiated the iodized oil plus Therapeutic treatment of anti-cancer drugs by transcatheter arterial chemoembolization has greatly improved the survival of patients with hepatocellular carcinoma